McKinsey August 21, 2025
With the support of McKinsey, the organization launched an expansion of clinical trial capacity at research sites across the United States, enabling more than 20 new trials and reaching over 4,600 participants to date.
Expanding participation in clinical research, community by community
Clinical research is the cornerstone of medical innovation, yet access to clinical trials remains disproportionately limited to a small fraction of the population.
Enter Clinical Trials Access Collaborative (CTAC), an organization dedicated to making medical research more accessible, striving to ensure those who wish to participate in clinical trials can do so. CTAC, which is currently applying for a 501(c)(3) status, grew from a preceding grant and learning phase, Equitable Breakthroughs in Medicine Development (EQBMED).
The...







